Show simple item record

dc.contributor.authorMiceli, Isabeles_ES
dc.contributor.authorKantor, Isabel N. dees_ES
dc.contributor.authorColaiacovo, Dianaes_ES
dc.contributor.authorPeluffo, Gracielaes_ES
dc.contributor.authorCutillo, Irenees_ES
dc.contributor.authorGorra, Robertoes_ES
dc.contributor.authorBotta, Robertoes_ES
dc.contributor.authorHom, Silviaes_ES
dc.contributor.authorTen Dam, H.Ges_ES
dc.date.accessioned2015
dc.date.available2015
dc.date.issueds.d.es_ES
dc.date.issued1988es_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/17850
dc.description.abstractA retrospective case control study was carried out between 1981 and 1984 in three hospitals in the western part of Greater Buenos Aires to determine protection provided by BCG tuberculosis vaccine in children under six years of age residing in a region of Argentina in which vaccination coverage is approximately 55 percent. A total of 175 cases of tuberculosis were included in the study. For each case five controls were selected (a total of 875) from among patients being treated in the same hospital for other causes unrelated to tuberculosis. The controls were selected on the basis of their similarity with the cases with respect to age, socioeconomic status, nutritional status, and place of residence. Information on the presence or absence of vaccination scarring and other data related to vaccination of both the cases and controls was collected by an independent examiner. In 152 of the 175 cases location of tuberculosis was pulmonary; in 15, miliary; and in six there were pleural complications. Of the remaining 23 cases, 18 were meningeal, two gangliar, two osteoarticular, and one otic. Diagnosis was based on bacteriological and histopathological analysis, computerized tomography, radiological and clinical examination, endoscopy, and verification of a focus of infection. The protective effect of BCG vaccine in vaccinated patients was 73 percent on average (CI95 percent = 62 to 85 percent)en_US
dc.format.extentgrafes_ES
dc.relation.ispartofseriesBoletín de la Oficina Sanitaria Panamericana (OSP);104(5),mayo 1988es_ES
dc.subjectVacina BCGpt_BR
dc.subjectVacina BCGpt_BR
dc.subjectTuberculosept_BR
dc.subjectTuberculosept_BR
dc.subjectArgentinaes_ES
dc.titleEficacia de la vacunacion con BCG evaluada mediante el metodo de casos y testigos en Buenos Aires, Argentinaes_ES
dc.title.alternativeEffectiveness of BCG vaccination evaluated by means of the case control method in Buenos Aires, Argentinaen_US
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record